Could stem cells and glutathione ease autism symptoms? new trial seeks answers

NCT ID NCT07304440

Recruiting now Disease control Sponsor: Adia Med of Winter Park LLC Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This 24-month study tests whether adding umbilical cord stem cells (AdiaVita) to glutathione therapy helps improve autism symptoms in children ages 3-12. About 100 kids will be randomly assigned to get either glutathione alone or glutathione plus stem cell infusions. Parents and therapists track symptoms using a checklist. The goal is to see if the combination reduces symptom severity more than glutathione alone.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: umbilical cord blood-derived stem cells and exosomes (AdiaVita) plus glutathione
What this could lead to: If it works, this could point toward a new combination therapy to ease autism symptoms in children.
What could go wrong: This is an early Phase 1/2 trial with only 100 children, so results may not apply broadly. The treatment is experimental and costs $12,000, with no guarantee of benefit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASD are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atrial septal defect autism autism spectrum disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ASD AUTISM AUTISM SPECTRUM DISORDER AUTISM SPECTRUM DISORDER (ASD

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Adia Med Of Winter Park
RECRUITING

Winter Park, Florida, 32789, United States

Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.